Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health In Tech (HIT) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Health In Tech (HIT) over the last 3 years, with Q1 2025 value amounting to $57.0 million.

  • Health In Tech's Shares Outstanding (Diluted Average) rose 1009.78% to $57.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $57.0 million, marking a year-over-year increase of 1009.78%. This contributed to the annual value of $53.7 million for FY2024, which is 1217.69% up from last year.
  • Health In Tech's Shares Outstanding (Diluted Average) amounted to $57.0 million in Q1 2025, which was up 1009.78% from $53.7 million recorded in Q4 2024.
  • In the past 5 years, Health In Tech's Shares Outstanding (Diluted Average) registered a high of $57.0 million during Q1 2025, and its lowest value of $47.8 million during Q4 2023.
  • For the 3-year period, Health In Tech's Shares Outstanding (Diluted Average) averaged around $52.6 million, with its median value being $52.7 million (2024).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 1217.69% in 2024, then skyrocketed by 1009.78% in 2025.
  • Quarter analysis of 3 years shows Health In Tech's Shares Outstanding (Diluted Average) stood at $47.8 million in 2023, then increased by 12.18% to $53.7 million in 2024, then grew by 6.21% to $57.0 million in 2025.
  • Its last three reported values are $57.0 million in Q1 2025, $53.7 million for Q4 2024, and $51.8 million during Q1 2024.